Order Article Reprints

Catalano A, Adlesic M, Kaltenbacher T, Klar RFU, Albers J, Seidel P, Brandt LP, Hejhal T, Busenhart P, Röhner N, et al. Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers. 2021; 13(8):1852. https://doi.org/10.3390/cancers13081852

Catalano, Antonella, Mojca Adlesic, Thorsten Kaltenbacher, Rhena F. U. Klar, Joachim Albers, Philipp Seidel, Laura P. Brandt, Tomas Hejhal, Philipp Busenhart, Niklas Röhner, and et al. 2021. "Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition" Cancers 13, no. 8: 1852. https://doi.org/10.3390/cancers13081852

Catalano, A., Adlesic, M., Kaltenbacher, T., Klar, R. F. U., Albers, J., Seidel, P., Brandt, L. P., Hejhal, T., Busenhart, P., Röhner, N., Zodel, K., Fritsch, K., Wild, P. J., Duyster, J., Fritsch, R., Brummer, T., & Frew, I. J. (2021). Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers, 13(8), 1852. https://doi.org/10.3390/cancers13081852